Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels - a review of routine practice

Br J Clin Pharmacol. 2017 May;83(5):1149-1151. doi: 10.1111/bcp.13201. Epub 2017 Jan 29.

Naomi Jessurun¹, Eugène P van Puijenbroek^{1

2}, Leila S Otten³, Oenone Mikes⁴, Annemieke Vermeulen Windsant⁵, Rob J van Marum^{5

6}, Koen Grootens⁴, Hieronymus J Derijks^{5

7}

¹ Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
² Department of Pharmacy: Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen, The Netherlands.
³ Department of Pharmacy, University of Utrecht, Utrecht, The Netherlands.
⁴ Reinier van Arkelgroep, 's-Hertogenbosch, The Netherlands.
⁵ Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
⁶ Department of General Practice & Elderly Care Medicine/EMGO Institute for Health and Care Research, VU University Medical Center Amsterdam, The Netherlands.
⁷ Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.

No abstract available

Publication types